Article Details

BioNTech initiated with a Neutral at Goldman Sachs - TipRanks.com

Retrieved on: 2025-05-29 10:25:10

Tags for this article:

Click the tags to see associated articles and topics

BioNTech initiated with a Neutral at Goldman Sachs - TipRanks.com. View article details on hiswai:

Excerpt

Goldman Sachs analyst Asad Haider initiated coverage of BioNTech (BNTX) with a Neutral rating and $110 price target representing 12% upside.

Article found on: www.tipranks.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo